Expert-led webinars that connect life sciences leaders with the insights, solutions and partners they need to move their work forward.
Developing Nasal Drug Delivery's Next Generation: Psychedelics and CNS
How formulation and manufacturing strategies are evolving to support nasal drug delivery's expansion beyond traditional local and systemic therapies
09/12/2026
HUGO-Nano: The Next Generation of Fully Human VHH Antibodies
HUGO-Nano mouse generates fully human, developable single-domain antibodies (VHHs) with no post-discovery humanization required.
19/11/2026
Advancing Autoinjector Platforms for Evolving Drug and Patient Needs
How adaptable platform technology can address diverse drug profiles, patient needs and brand requirements without starting device development from scratch.
03/12/2026
Feasibility to Phase I: How Early Development Decisions Save Time and Cost
Discover how to assess API suitability for oral films and transdermal patches, reduce time and cost, and optimise formulations
17/09/2026
Characterize Your Biologics with Smart and Science-driven Concepts
How to choose the best panel of phase-appropriate analytical methods for complex modalities while maintaining aggressive development timelines
09/07/2026
Sterile Drug Products: Phase I Development in a Post-Annex 1 Environment
Annex 1 has raised the bar for sterile drug product development. A structured single-site approach could be the fastest route to Phase I.
23/07/2026
Hypodermic Needle
Secure your Value Proposition
by Co-Packing
Needle choice is rarely a headline decision, yet it contributes to the treatment experience and efficacy.
24/09/2026
Stability by design: Connecting formulation science and primary packaging strategy
Learn how early formulation and primary packaging integration reduces risk for high-concentration, large-volume biologics.
01/12/2026
Packaging Precision: Insights on Ensuring Stability and Shelf-Life
Capsule and packaging material selection for OSD formulations, strategies for overcoming stability challenges and cost optimisation during scale up.
07/03/2024
Master the Next Generation of Clinical Research: 5 Strategies to Dramatically Improve Data Quality
Five strategies for clinical data quality, covering data management, risk based quality management, AI assisted review and proactive error detection.
08/05/2024
Preservative-Free Spray Applications and Their Compliant Road to Market
Preservative-free spray system options, drug device combination under EU MDR and regulatory documentation requirements for market entry.
27/06/2024
Innovative Solutions in Pre-Filled Syringes for Biologics and Ophthalmic Applications
Selecting the right pre-filled syringe for biologics and ophthalmic applications, covering plasma coating, viscosity, compatibility and analytics.
11/07/2024
Sharpening the Future: New Opportunities for Implant Injection
Drug implant technology advances, applicator design, manufacturing quality standards and market opportunities for long acting implant systems.
01/10/2024
Unlocking Success in Inhaled & Nasal Drug Clinical Studies
Critical factors in OINDP clinical development, CMC risk mitigation and how to balance preparation levels to meet regulatory expectations.
22/10/2024
How RTU Solutions Can Meet GMP Annex 1 Requirements
Pre-sterilised ready to use containers as a compliant aseptic solution, reducing contamination risk and simplifying EU GMP Annex 1 compliance.
14/11/2024
Transitioning an Oral Solid Dosage from Phase 1 to Phase 2 studies: Formulation challenges and strategies
Development timelines, formulation optimisation strategies and CDMO selection for transitioning oral solid dosage forms from Phase 1 to Phase 2.
26/02/2025
EU GMP Annex 1: New Standards for Injectable Drug Manufacturing
Revised EMA GMP Annex 1 guidelines, impact on contamination control strategy and the role of primary packaging suppliers in sterility assurance.
08/04/2025
Advancements in On-Body Drug Delivery Systems: Overcoming Challenges and Driving Innovation
Advances in on-body delivery for high volume and viscous drugs, with strategies for optimising platforms from prototype through to clinical readiness.
10/04/2025
Overcoming Challenges in Preclinical Studies for Intranasal and Inhalation Programs
Preclinical intranasal and inhalation protocols, covering system selection, animal model design, insufflator and micro sprayer technologies.
29/05/2025
Unlocking the Future of Drug Development: How PBBM & Solid Form Screening Drive Early-Phase Success
Solid form screening, PBBM modelling and in vitro testing to identify absorption risks, guide form selection and accelerate early phase development.
05/06/2025
Navigating the sterile fill finish CDMO landscape for development and manufacturing success
CDMO capability assessment, facility design, EU GMP Annex 1 compliance and formulation strategies for sterile liquid and powder drug products.
25/06/2025
Targeting the Airways: Innovations in Soft Mist Drug Delivery for All Ages – Including Infants
Soft mist aerosol technology for targeted respiratory deposition across all age groups, including a pacifier-based delivery interface designed for infants.
09/07/2025
Could Transmucosal Delivery Be the Right Route for Your API?
API requirements for transmucosal delivery, Mucofilm compatibility and key development steps from feasibility through to commercial manufacture.
10/09/2025
Managing the uncertainty in treatment exposure to increase success in clinical trials
Digital adherence monitoring, RBQM integration and the estimand framework to reduce trial variability and strengthen exposure response analysis.
16/09/2025
Holistic approach to Intravitreal Injection combining Packaging and Device
The full value chain for intravitreal injection, from primary packaging and coating technology to filtered needle selection and USP 789 particle compliance.
18/09/2025
Nose-to-Brain Drug Delivery and Device Selection
Key delivery targets, transport mechanisms and device considerations for nose to brain CNS delivery, from formulation to regulatory submission.
01/10/2025
Unlocking Therapeutic Potential Through Nasal Drug Repositioning
Evaluating nasal repositioning potential, covering clinical suitability, regulatory strategy, delivery system selection and commercial impact.
13/11/2025
Scaling Up Oral Solid Dose Manufacturing for Late-Phase Success
How to select the right CDMO, translate lab data into scalable OSD processes and apply QbD principles to avoid delays in late-phase manufacturing.
25/03/2026
Moving circularity forward in medical device packaging
Learn how Tyvek® with Renewable Attribution is helping accelerate circularity in medical device packaging.
24/11/2026
Developability Assessment and Early Formulation Studies for Biologics
Candidate selection, biophysical characterisation and pre-formulation screening to reduce late stage failures and build a strong data foundation.
27/02/2025
Paving the way to a successful AAV product
Analytical methods for AAV characterisation, quality attributes for manufacturing and orthogonal approaches for infectivity and capsid ratios.
20/11/2024
Lyo-Modelling Reduce risks on the road to commercialization through process understanding
Lyophilisation modelling for primary drying optimisation, robustness analysis and in silico assessment of process failures to ensure product quality.
10/07/2024
Shedding light on surfactants used as excipient for biologics
Polysorbate degradation mechanisms, surfactant characterisation strategies and multidimensional chromatography for surfactant analysis in biologics.
07/05/2024
Road To Success: Mapping drug development from preclinical to commercialization
A phase appropriate development roadmap for biologics, covering formulation, analytical characterisation and derisking from preclinical to market.
21/02/2024
Every particle matters
Particle identification and characterisation tools for biologics and cell and gene therapy, covering origins, analytical methods and troubleshooting.
29/11/2023
Smarter Drug Development for Biologics with In Silico Modelling
Computational approaches to biologics developability, formulation optimisation and stability prediction, with case studies on risk reduction.
01/07/2025
Subvisible Particle Analysis: Ensuring Quality from Lab Bench to GMP
Regulatory requirements, method validation and variability control for subvisible particle analysis from R&D through to GMP compliance.
18/11/2025
Formulating the Future:
Nucleic Acid Therapeutics Explained
Critical quality attributes for mRNA-LNP formulations, LNP delivery system stability and the analytical toolbox for nucleic acid therapeutics.
05/03/2026
Simplifying ADC Development: An Integrated Path from Concept to Commercialization
Best practices for scalable ADC manufacturing, end to end integration and reducing complexity across the full ADC development lifecycle.
25/06/2026
01/12/2026
03/12/2026
09/12/2026
17/09/2026
23/07/2026
09/07/2026
25/06/2026
18/11/2025
16/09/2025
18/09/2025
09/07/2025
25/06/2025
29/05/2025
05/06/2025
21/02/2024
07/03/2024
08/05/2024
10/04/2025
27/06/2024
11/07/2024
10/07/2024
27/02/2025
26/02/2025
Pharma webinar services that reach the right audience. We run webinar campaigns for pharma, biotech and medtech organisations, from audience targeting and promotion through to live delivery and follow up. Our webinars average a 42% engagement rate.
Every programme starts with one question: who needs to hear this? Our webinar services for pharma begin with the people who register, so they are the decision makers your objectives depend on. Before we plan a session, we agree the audience, the job role and the decision each attendee is likely to make. That shapes the speaker, the promotion and the follow up.
Each campaign is then shaped around the problem your audience is trying to solve, whether that is formulation, clinical development, regulatory readiness or manufacturing. A session for formulation scientists needs different language and evidence from one for clinical leads, so we tailor the programme to match.
Our webinar services for pharma, biotech and medtech cover the full value chain, from early development and formulation through to CDMO selection, sterile manufacturing and scale up. Pharma sessions often focus on manufacturing, Annex 1 compliance and the choice of CDMO, while also covering regulatory expectations for each stage.
Biotech sessions cover biologics characterisation, developability and analytics for antibodies, ADCs and gene therapies. These topics need early data and clear decisions, so the sessions are built to help teams choose methods, assess risk and move forward with confidence.
Medtech sessions focus on the devices and packaging that deliver those products, from autoinjectors and prefilled syringes to needles and packaging compliance. Device and packaging decisions affect usability, supply and regulatory submissions, so we cover how those choices connect to the drug itself.
Our webinar services for pharma handle the whole session, from live presentation management and speaker coordination to Q&A, polls, technical support and recording capture. Our team manages the technical side from the first rehearsal to the final recording, so your speakers can focus on the content.Sessions run cleanly from start to finish, and any issues on the day are resolved in real time. Attendees get a smooth experience, and you get a recording you can use after the event.
Within our webinar services for pharma, audience engagement starts before the webinar, with targeted email and LinkedIn outreach that builds interest in advance. During the session, attendees take part through live Q&A and polls, which shows what the audience cares about. After the event, we send personalised outreach and nurture sequences, so that interest turns into conversations.Within our webinar services for pharma, audience engagement starts before the webinar.
Ready to plan your next programme? Tell us your therapeutic area, target audience and timeline, and we will suggest a format, speaker profile and schedule. For wider reach, our executive events bring senior leaders together in invite-only settings, and Industry Intelligence gives your audience context beyond a single session. For background on the regulations many of our sessions cover, the EU GMP guidelines are a useful starting point.
We connect you with engaged life sciences professionals across Pharma, biotech and medtech.
High-quality, independent content developed with industry experts and trusted by your peers.
Our webinars deliver exceptional engagement, with an average engagement rate of 42%.
From strategy and promotion to delivery and follow-up, we handle every detail.
Expert-led webinars that connect life sciences leaders with the insights, solutions and partners they need to move their work forward.